NutraLife Echinacea Advanced Immune 60 Tablets

NutraLife Echinacea Advanced Immune 60 Tablets

Be the first to review this product

Availability: In stock


RRP: $48.99

You will earn 32 Points for buying this product

With Echinacea from two sources. Plus immunity-supporting Zinc, Selenium and Vitamin C.

NutraLife Echinacea Advanced Immune 60 Tablets


This formula combines two Echinacea extracts with antioxidant nutrients to support the body’s immune defences against colds and other upper respiratory tract infections.

Recommended for:

  • Relieve cold symptoms
  • Manage upper respiratory tract infections
  • Support a healthy immune response


Each tablet provides

Herbal extracts equiv. dry Echinacea purpurea (Echinacea) root 1.5g;
Echinacea angustifolia (Echinacea) root 500mg;
Astragalus membranaceus root 150mg,
Cofactors Calcium ascorbate 150mg
Equiv. Ascorbic acid (Vitamin C) 124mg;
Zinc (as gluconate) 5mg;
Betacarotene (Pro-vitamin A) 3mg;
Selenium (as Selenomethionine) 25μg.
Tabletting aids, colours.


Adults: Take 1-2 tablets daily, or as directed by your healthcare professional. If symptoms persist consult your healthcare professional. Not suitable for children under 2 years of age without medical advice.

Formulated without: Gluten, wheat, animal products, dairy products, egg, soy, artificial sweeteners. Suitable for vegetarians.

Cautions & Contraindications:

This product contains Selenium which is toxic in high doses. A daily dose of 150µg for adults of Selenium from dietary supplements should not be exceeded. Vitamin supplements should not replace a balanced diet.


Additional Information

Manufacturer's Suggested Retail Price $48.99

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.

Subscribe to our newsletter by providing your email address below and get FREE SHIPPING on your first order! You will receive an email shortly with the free shipping code which you can use on your first purchase. Tip: keep a lookout in your junk email box.

Free Shipping when you signup to the newsletter